Core Viewpoint - The legal opinion letter confirms the legality and validity of the procedures, qualifications, and voting results of the 2025 third extraordinary general meeting of shareholders of Chongqing Pharmaceutical Holdings Co., Ltd. [2][8] Group 1: Meeting Procedures - The meeting was convened by the board of directors and held on July 28, 2025, at the company's conference room in Chongqing, with proper notification of time, location, and agenda [3][4] - The voting was conducted through both on-site and online platforms, with specific time slots for each [3][4] Group 2: Attendance and Qualifications - A total of 247 shareholders and their proxies attended the meeting, representing 1,025,248,471 shares, which is 59.3252% of the total voting shares [4][5] - The qualifications of the attendees and the convenor were verified to be in compliance with relevant laws and regulations [4][8] Group 3: Agenda and Voting Results - The meeting reviewed and voted on the agenda items as previously announced, with no additional temporary motions presented [5][8] - The voting results showed that 1,014,780,662 shares (98.9790%) were in favor, 10,263,109 shares (1.0010%) were against, and 204,700 shares (0.0200%) were abstained [5][6][7]

中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层 邮政编码 100025 电话: (86-10) 5809-1000 传真: (86-10) 5809-1100 本所律师根据出席本次股东会所掌握的事实和公司提供的文件资料，按照现 行法律、法规的要求发表法律意见。为出具本法律意见书，本所律师对本次股东 会所涉及的有关事项进行了审查，查阅了相关会议文件，并对有关问题进行了必 要的核查和验证。本所律师得到公司如下保证，即其已提供了本所律师认为作为 出具本法律意见书所必需的全部文件资料，所提供的文件资料和陈述均符合真实、 准确、完整的要求，无重大遗漏和误导性陈述，有关副本和复印件分别与正本和 原件一致。 在本法律意见书中，本所律师仅对本次股东会的召集、召开程序、出席会议 北京市竞天公诚律师事务所 1 关于重药控股股份有限公司 2025 年第三次临时股东会的 人员和召集人的资格、会议表决程序及表决结果是否符合《公司法》《证券法》 《上市公司股东会规则》等法律、法规、规范性文件及《公司章程》的规定发表 意见，不对会议审议的议案内容以及该等议案所表述的事实或数据的真实性、准 确性和完整性发表意见。本法律意见 ...

证券代码：000950 证券简称：重药控股 公告编号：2025-050 重药控股股份有限公司 2025年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.本次股东会没有出现否决议案的情形。 2.本次股东会不涉及变更前次股东会决议。 一、会议召开情况 （一）现场会议召开时间：2025 年 7 月 28 日（星期一）14:00。 网络投票时间：2025 年 7 月 28 日。其中： （五）现场会议主持人：董事刘伟先生。 （六）本次股东会的召开符合《公司法》、《深圳证券交易所股票上市规则》 等法律法规、规范性文件及《公司章程》的规定。 （七）公司于 2025 年 7 月 12 日、2025 年 7 月 24 日分别在巨潮资讯网 www.cninfo.com.cn 及《中国证券报》、《证券时报》、《证券日报》、《上海证 券报》上刊登了《关于召开 2025 年第三次临时股东会的通知》、《关于召开 2025 年第三次临时股东会的提示性公告》。 二、会议出席情况 （一）出席现场会议及网络投票股东情况 股东出席的总体情况：通过现场和 ...

证券代码：000950 证券简称：重药控股 公告编号：2025-049 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 重药控股股份有限公司于 2025 年 7 月 10 日召开第九届董事会第十五次会议 审议通过了《关于回购公司股份的议案》，具体内容详见公司于 2025 年 7 月 12 日在巨潮资讯网披露的《关于回购股份方案的公告》（公告编号：2025-042）。 本次回购股份方案将在 2025 年 7 月 28 日召开的 2025 年第三次临时股东会上进 行审议。 根据《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等有关 规定，现将公司 2025 年第三次临时股东会的股权登记日（2025 年 7 月 23 日） 登记在册的前十名股东和前十名无限售条件股东的名称、持股数量及持股比例情 况公告如下： 重药控股股份有限公司 关于回购股份事项前十名股东和前十名无限售条件 股东持股情况的公告 一、前十名股东持股情况 | 序号 | 股东名称 | 持股数量（股） | 持股比例% | | --- | --- | --- | --- | | 10 | 招商银行 ...

重药控股股份有限公司 关于召开 2025 年第三次临时股东会的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整， 没有虚假记载、误导性陈述或者重大遗漏。 证券代码：000950 证券简称：重药控股 公告编号：2025-048 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 7 月 28 日 9:15-9:25，9:30-11:30，13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 7 月 28 日 本次股东会采取现场投票和网络投票相结合的方式。公司将通过深圳证券交 易所交易系统和互联网投票系统（http://wltp.cninfo.com.cn）向全体股东提供网 络形式的投票平台，公司股东可以在上述网络投票时间内通过上述系统行使表决 权。 重药控股股份有限公司（以下简称"公司"）于 2025 年 7 月 12 日在《中国 证券报》、《证券时报》、《证券日报》、《上海证券报》及巨潮资讯网 （http://www.cninfo.com.cn）上刊登了《关于召开 2025 年第三次临时股东会的通 知》（公告编号：2025-045）。本次股东会将 ...

证券代码：000950 证券简称：重药控股 公告编号：2025-048 重药控股股份有限公司 关于召开 2025 年第三次临时股东会的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整， 没有虚假记载、误导性陈述或者重大遗漏。 重药控股股份有限公司（以下简称"公司"）于 2025 年 7 月 12 日在《中国 证券报》、《证券时报》、《证券日报》、《上海证券报》及巨潮资讯网 （http://www.cninfo.com.cn）上刊登了《关于召开 2025 年第三次临时股东会的通 知》（公告编号：2025-045）。本次股东会将采用现场投票与网络投票相结合的 方式进行，现再次将本次股东会的有关事项提示如下： 一、召开会议的基本情况 1.股东会届次：2025 年第三次临时股东会 2.股东会召集人：重药控股股份有限公司董事会 3.会议召开的合法性和合规性：公司第九届董事会第十五次会议审议通过了 《关于召开 2025 年第三次临时股东会的议案》，本次股东会会议召开符合有关 法律、行政法规、部门规章、规范性文件和公司章程的有关规定。 4.会议召开的日期和时间： （1）现场会议召开时间：2025 年 7 月 ...

Core Viewpoint - The company has announced a share repurchase plan approved by its board of directors, detailing the top ten shareholders and their respective holdings as of the day before the announcement [1][2]. Group 1: Share Repurchase Announcement - The board of directors of Chongqing Pharmaceutical Holdings Co., Ltd. approved a share repurchase plan on July 10, 2025 [1]. - The details of the share repurchase plan were disclosed on July 12, 2025, in a separate announcement [1]. Group 2: Top Ten Shareholders - The announcement includes the names, share quantities, and ownership percentages of the top ten shareholders as of July 11, 2025 [1]. - The top shareholder is Chongqing Yufu Capital Equity Investment Fund Management Co., Ltd. with a significant holding [1]. - The second shareholder is China Merchants Bank Co., Ltd. - Southern CSI 1000 ETF, indicating a diversified shareholder base [1]. Group 3: Top Ten Unrestricted Shareholders - The same entities listed as top shareholders are also noted as the top ten unrestricted shareholders, reflecting consistency in ownership [2]. - The holdings are reported as the total number of shares after combining ordinary accounts and margin trading accounts [2].

根据《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等有关 规定，现将公司披露董事会公告回购股份决议的前一个交易日（2025 年 7 月 11 日）登记在册的前十名股东和前十名无限售条件股东的名称、持股数量及持股比 例情况公告如下： | 序号 | 股东名称 | 持股数量（股） | 持股比例% | | --- | --- | --- | --- | | 1 | 重庆医药健康产业有限公司 | 664,900,806 | 38.47 | | 2 | 重庆市城市建设投资（集团）有限公司 | 282,294,397 | 16.33 | | 3 | 重庆渝富资本股权投资基金管理有限公司－重庆 战略性新兴产业医药专项股权投资基金合伙企业 | 55,592,526 | 3.22 | | | （有限合伙） | | | | 4 | 邓守宽 | 26,071,200 | 1.51 | | 5 | 广州白云山医药集团股份有限公司 | 25,992,330 | 1.50 | | 6 | 上海复星医药（集团）股份有限公司 | 17,186,726 | 0.99 | | 7 | 香港中央结算有限公司 | 12,883,351 ...

Group 1 - The company expects to achieve a net profit of 250 million to 280 million yuan for the first half of 2025, representing a year-on-year growth of 14.39% to 28.12% after deducting non-recurring gains and losses [1] - The forecasted net profit attributable to shareholders is estimated to be between 260 million and 300 million yuan, with a year-on-year increase of 9.2% to 26% [1] - The company plans to repurchase shares using its own funds and a special loan for stock repurchase, with a total amount not less than 80 million yuan and not exceeding 100 million yuan [1] Group 2 - The repurchase price will not exceed 6.6 yuan per share, with an estimated repurchase quantity of approximately 15.15 million shares, accounting for about 0.88% of the current total share capital [2] - The estimated repurchase quantity could be around 12.12 million shares, representing about 0.70% of the total share capital, based on the lower limit of the repurchase funds [2] - The funding for the repurchase will come from the company's own funds and a special loan, with a commitment from China Everbright Bank to provide up to 90 million yuan for the stock repurchase [2]

Core Viewpoint - This week, 10 listed companies announced share buybacks and increases in shareholdings, with notable mention of Three Gorges Energy's controlling shareholder receiving a loan commitment of up to 2.7 billion yuan specifically for increasing its stake in the company [1][2]. Group 1: Companies Announcing Buybacks or Increases - Chongqing Pharmaceutical Holdings plans to repurchase shares worth 80 million to 100 million yuan, with a loan not exceeding 90 million yuan [2]. - Antong Holdings intends to increase its shareholding by 360 million to 720 million yuan [2]. - Renfu Pharmaceutical's shareholder received a loan commitment of 750 million yuan [2]. - ST Kelly's shareholder plans to increase its stake by no less than 14.39 million shares [2]. - Trina Solar has obtained a special loan commitment for stock repurchase [2]. - Suobede plans to repurchase shares worth 20 million to 30 million yuan for cancellation [2]. - Yanpai Co.'s controlling shareholder's concerted actor intends to increase holdings by 17 million to 34 million yuan [2]. - Hisense Home Appliances plans to continue increasing its holdings by 6.93 million to 13.86 million shares [2]. - Three Gorges Energy's controlling shareholder received a loan commitment of 2.7 billion yuan for shareholding increase [2]. - Xishan Technology's controlling shareholder plans to increase holdings by no less than 5 million yuan and no more than 10 million yuan [2].